Older Black male veterans with diabetes, liver issues, and depression who take SGLT2 inhibitor pills tend to weigh less than those on GLP-1 shots, even though both types of medicine usually help people lose weight.

Older Black male veterans with diabetes, fatty liver, and depression who take GLP-1 drugs like semaglutide have slightly lower depression scores than those on SGLT2 drugs, but the difference isn’t big enough to be sure it’s not just by chance.

Older Black male veterans with diabetes, fatty liver, and depression who take GLP-1 drugs (like Ozempic) seem to have less liver scarring than those on SGLT2 drugs, based on a blood test score — but the difference isn’t strong enough to be sure it’s not just by chance.

In older Black male veterans with diabetes, fatty liver, and depression, how bad their depression is doesn't seem to be linked to how much scarring their liver has — especially if they're taking certain diabetes meds like GLP-1 drugs or SGLT2 inhibitors.

Losing just 1 kilogram (about 2.2 pounds) of body weight while taking GLP-1 diabetes drugs is linked to a 7% lower chance of having a heart attack, stroke, or dying from heart disease.

People with type 2 diabetes who take SGLT-2 inhibitors tend to have lower fasting insulin levels than those using other diabetes drugs.